SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 332 filers reported holding SEATTLE GENETICS INC in Q3 2018. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $1,844,378 | +12.2% | 9,425 | -2.5% | 0.03% | +10.3% |
Q2 2020 | $1,643,126 | +74.3% | 9,670 | +18.3% | 0.03% | +45.0% |
Q1 2020 | $942,770 | -0.7% | 8,171 | -1.7% | 0.02% | +25.0% |
Q4 2019 | $949,615 | +31.4% | 8,311 | -1.8% | 0.02% | +33.3% |
Q3 2019 | $722,911 | +30.7% | 8,465 | +5.9% | 0.01% | +33.3% |
Q2 2019 | $553,057 | -7.6% | 7,991 | -2.3% | 0.01% | -18.2% |
Q1 2019 | $598,810 | +26.6% | 8,176 | -2.0% | 0.01% | +22.2% |
Q4 2018 | $472,941 | -25.9% | 8,347 | +0.9% | 0.01% | -18.2% |
Q3 2018 | $638,014 | -99.9% | 8,273 | -2.0% | 0.01% | +22.2% |
Q2 2018 | $560,199,000 | +36.0% | 8,438 | +7.2% | 0.01% | +50.0% |
Q1 2018 | $411,864,000 | +107717.8% | 7,869 | +10.1% | 0.01% | +20.0% |
Q4 2017 | $382,000 | -2.8% | 7,147 | -0.9% | 0.01% | +150.0% |
Q3 2017 | $393,000 | +11.0% | 7,215 | +5.4% | 0.00% | 0.0% |
Q2 2017 | $354,000 | -14.7% | 6,847 | +3.6% | 0.00% | -33.3% |
Q1 2017 | $415,000 | +18.9% | 6,607 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $349,000 | -6.4% | 6,607 | -4.3% | 0.00% | 0.0% |
Q3 2016 | $373,000 | +27.7% | 6,903 | -4.6% | 0.00% | +50.0% |
Q2 2016 | $292,000 | +5.4% | 7,235 | -8.5% | 0.00% | 0.0% |
Q1 2016 | $277,000 | -22.0% | 7,906 | 0.0% | 0.00% | -33.3% |
Q4 2015 | $355,000 | +33.0% | 7,906 | +14.2% | 0.00% | +50.0% |
Q3 2015 | $267,000 | -20.3% | 6,923 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $335,000 | +32.9% | 6,923 | -2.8% | 0.00% | 0.0% |
Q1 2015 | $252,000 | +10.0% | 7,126 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $229,000 | -11.2% | 7,126 | +2.7% | 0.00% | 0.0% |
Q3 2014 | $258,000 | -3.4% | 6,936 | -0.7% | 0.00% | 0.0% |
Q2 2014 | $267,000 | -15.2% | 6,988 | +1.2% | 0.00% | 0.0% |
Q1 2014 | $315,000 | +14.5% | 6,906 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $275,000 | -9.2% | 6,906 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $303,000 | +37.7% | 6,906 | -1.3% | 0.00% | 0.0% |
Q2 2013 | $220,000 | – | 6,999 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 51,046,060 | $2,892,270,000 | 23.68% |
Lagoda Investment Management, L.P. | 88,615 | $5,021,000 | 8.38% |
Matrix Capital Management Company, LP | 3,141,852 | $178,017,000 | 5.90% |
Opus Point Partners Management, LLC | 19,127 | $1,084,000 | 2.39% |
EMORY UNIVERSITY | 41,539 | $2,354,000 | 1.86% |
Capital International Sarl | 238,100 | $13,491,000 | 1.62% |
Rhenman & Partners Asset Management AB | 242,198 | $13,723,000 | 1.57% |
CAPITAL GUARDIAN TRUST CO | 1,341,050 | $75,984,000 | 1.21% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 42,500 | $1,890,000 | 1.17% |
JGP Global Gestao de Recursos Ltda. | 16,524 | $936,000 | 1.14% |